One-quarter of systemic lupus erythematosus patients in the U.S. taking hydroxychloroquine tablets daily are exceeding the recommended doses for this…
Articles by Iqra Mumal, MSc
In Asian patients with systemic lupus erythematosus, pulmonary arterial hypertension (PAH) is more prevalent and associated with worse overall survival rates…
The immunosuppressive agent tacrolimus, used in combination with other immunosuppressants, was deemed safe and effective for treatment of lupus nephritis,…
Levels of circulating cell-free DNA can potentially be used as a biomarker for assessing disease activity and monitoring treatment effectiveness…
Hydroxychloroquine, an antimalarial medication, can help normalize levels of an immune molecule that promotes inflammation in patients with…
Patients participating in Phase 3 clinical trials testing new therapies for systemic lupus erythematosus (SLE) are not necessarily representative…
Skepticism as to whether physicians or other providers should determine one’s health, along with the perception that a medicine is…
Designing therapeutics that block cGAS–STING — a cell-signaling pathway associated with inflammation — could help treat patients with systemic lupus…
Levels of certain antibodies are significantly associated with particular clinical characteristics of systemic lupus erythematosus (SLE), and could be…
The relationship between emotional health and work/regular activities of daily living is influenced by the use of corticosteroids in women…